Sponsors: protect your clinical trial.

Independent. Objective. Evidence-based. Clinical Execution Assessment for sponsors.

Sponsors — protect your clinical trial.

An independent clinical execution assessment gives you a clear view of where your trial stands — before regulators do.

• Independent. We are not your CRO. We provide an independent clinical execution assessment for sponsors.
• Objective. We assess the evidence, identify material issues and report objectively so you can make informed decisions.
• Accountable. You remain accountable for the trial. We provide clarity to support your decisions and oversight.

What CPT delivers — Clinical Execution Assessment for sponsors

• Independent clinical execution findings: Findings on execution and compliance against applicable regulatory and ICH expectations.
• Inspection exposure: Assessment of potential areas of regulatory inspection focus.
• Executive risk findings: Evidence-based findings on material risks affecting your clinical program.
• Documented findings & materiality: Clear, prioritized findings based on evidence.
• Sponsor oversight findings: Visibility into where oversight may be strengthened across key interfaces.

Executive value — informed decisions, greater control

• Greater executive visibility: Clear view of compliance, inspection exposure and execution risks.
• Earlier risk identification: Understand material issues before they escalate.
• Stronger oversight: Support informed governance and more effective sponsor oversight.
• Better decision-making: Independent, evidence-based insight for leadership and the board.
• Enterprise risk visibility: Understand material exposure across your clinical program.

Request an independent Clinical Execution Assessment — Identify gaps. Understand exposure. Strengthen oversight.